The Transcriptomic Landscape of Prostate Cancer Development and Progression: An Integrative Analysis

被引:6
|
作者
Marzec, Jacek [1 ]
Ross-Adams, Helen [1 ]
Pirro, Stefano [1 ]
Wang, Jun [1 ]
Zhu, Yanan [2 ]
Mao, Xueying [2 ]
Gadaleta, Emanuela [1 ]
Ahmad, Amar S. [3 ]
North, Bernard V. [3 ]
Kammerer-Jacquet, Solene-Florence [2 ]
Stankiewicz, Elzbieta [2 ]
Kudahetti, Sakunthala C. [2 ]
Beltran, Luis [4 ]
Ren, Guoping [5 ]
Berney, Daniel M. [2 ,4 ]
Lu, Yong-Jie [2 ]
Chelala, Claude [1 ,6 ]
机构
[1] Queen Mary Univ London, Barts Canc Inst, Bioinformat Unit, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[2] Queen Mary Univ London, Barts Canc Inst, Ctr Canc Biomarkers & Biotherapeut, London EC1M 6BQ, England
[3] Queen Mary Univ London, Wolfson Inst Prevent Med, Barts & London Sch Med, Ctr Canc Prevent, London EC1M 6BQ, England
[4] Barts Hlth NHS, Dept Pathol, London E1 F1R, England
[5] Zhejiang Univ, Med Coll, Dept Pathol, Affiliated Hosp 1, Hangzhou 310058, Peoples R China
[6] Queen Mary Univ London, Life Sci Initiat, Ctr Computat Biol, London EC1M 6BQ, England
基金
英国工程与自然科学研究理事会;
关键词
prostate cancer; tumorigenesis; mRNA; RNAseq; transcriptomic; data integration;
D O I
10.3390/cancers13020345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary There is a tremendous amount of gene expression information available for prostate cancer, but very few tools exist to combine the disparate datasets generated across sample types and technical platforms. We present a method of integrating different types of expression data from different study cohorts to increase analytic power, and improve our understanding of the molecular changes underlying the development and progression of prostate cancer from normal to advanced disease. Using this approach, we identified nine additional disease stage-specific candidate genes with prognostic significance, which were not identified in any one study alone. We have developed a free online tool summarizing our results, and making the complete combined dataset available for further translational research. Next-generation sequencing of primary tumors is now standard for transcriptomic studies, but microarray-based data still constitute the majority of available information on other clinically valuable samples, including archive material. Using prostate cancer (PC) as a model, we developed a robust analytical framework to integrate data across different technical platforms and disease subtypes to connect distinct disease stages and reveal potentially relevant genes not identifiable from single studies alone. We reconstructed the molecular profile of PC to yield the first comprehensive insight into its development, by tracking changes in mRNA levels from normal prostate to high-grade prostatic intraepithelial neoplasia, and metastatic disease. A total of nine previously unreported stage-specific candidate genes with prognostic significance were also found. Here, we integrate gene expression data from disparate sample types, disease stages and technical platforms into one coherent whole, to give a global view of the expression changes associated with the development and progression of PC from normal tissue through to metastatic disease. Summary and individual data are available online at the Prostate Integrative Expression Database (PIXdb), a user-friendly interface designed for clinicians and laboratory researchers to facilitate translational research.
引用
收藏
页码:1 / 24
页数:25
相关论文
共 50 条
  • [21] Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
    Chmelar, Renee
    Buchanan, Grant
    Need, Eleanor F.
    Tilley, Wayne
    Greenberg, Norman M.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (04) : 719 - 733
  • [22] Impact of Vasectomy on the Development and Progression of Prostate Cancer: Preclinical Evidence
    Kawahara, Takashi
    Teramoto, Yuki
    Li, Yi
    Ishiguro, Hitoshi
    Gordetsky, Jennifer
    Yang, Zhiming
    Miyamoto, Hiroshi
    CANCERS, 2020, 12 (08) : 1 - 15
  • [23] The Evolving Role of Oestrogens and Their Receptors in the Development and Progression of Prostate Cancer
    Bonkhoff, Helmut
    Berges, Richard
    EUROPEAN UROLOGY, 2009, 55 (03) : 533 - 542
  • [24] Genomic Signatures Associated with the Development, Progression, and Outcome of Prostate Cancer
    Prateek Mendiratta
    Phillip G. Febbo
    Molecular Diagnosis & Therapy, 2007, 11 : 345 - 354
  • [25] Chronic inflammatory mediators enhance prostate cancer development and progression
    Thapa, Dinesh
    Ghosh, Rita
    BIOCHEMICAL PHARMACOLOGY, 2015, 94 (02) : 53 - 62
  • [26] Integrative analysis of exosomal ncRNAs and their regulatory networks in liver cancer progression
    Mirzaei-nasab, Farzin
    Majd, Ahmad
    Seyedena, Yousef
    Hosseinkhan, Nazanin
    Farahani, Najma
    Hashemi, Mehrdad
    PRACTICAL LABORATORY MEDICINE, 2025, 45
  • [27] Integrative analysis of AR-mediated transcriptional regulatory network reveals IRF1 as an inhibitor of prostate cancer progression
    Cheng, Yihang
    Wang, Dan
    Jiang, Jun
    Huang, Wenhua
    Li, Dujian
    Luo, Jun
    Gu, Wei
    Mo, Wenjuan
    Wang, Chenji
    Li, Yao
    Gu, Shaohua
    Xu, Yaoting
    PROSTATE, 2020, 80 (08) : 640 - 652
  • [28] Comprehensive analysis of the impact of emerging flame retardants on prostate cancer progression: The potential molecular mechanisms and immune infiltration landscape
    Xu, Xinchi
    Zhang, Dong
    Zhao, Kai
    Liu, Zhanpeng
    Ren, Xiaohan
    Zhang, Xu
    Lu, Zhongwen
    Qin, Chao
    Wang, Jiawei
    Wang, Shangqian
    TOXICOLOGY, 2024, 501
  • [29] Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer
    Mou, Zhuofan
    Spencer, Jack
    Mcgrath, John S.
    Harries, Lorna W.
    HUMAN GENOMICS, 2023, 17 (01)
  • [30] The study landscape for prostate cancer
    Miller, K
    UROLOGE, 2005, 44 (12): : 1431 - 1434